HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy